FDA panel sees link between paclitaxel devices, patient death risk - Star Tribune

FDA panel sees link between paclitaxel devices, patient death risk  Star Tribune

Experts worry that its use for blocked leg arteries is linked to patient deaths.



Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management